Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial

Despite lithium's being the most effective drug for bipolar disorder and in clinical use for decades, we still know very little about its early effects relevant to its mode of action.The Oxford Lithium Trial is a double-blind, randomised, placebo-controlled study of 6-week lithium treatment in...

詳細記述

書誌詳細
主要な著者: Saunders, K, Cipriani, A, Rendell, J, Attenburrow, M, Nelissen, N, Bilderbeck, A, Vasudevan, S, Churchill, G, Goodwin, G, Nobre, A, Harmer, C, Harrison, P, Geddes, J
フォーマット: Journal article
言語:English
出版事項: BioMed Central 2016

類似資料